3rd Circ. Wellbutrin Case Could Guide Patent Settlements
The Third Circuit recently held oral arguments in litigation accusing GlaxoSmithKline of paying generic-drug makers to withhold their versions of antidepressant Wellbutrin XL from the market, and experts said the court's...To view the full article, register now.
Already a subscriber? Click here to view full article